F522-0331 Screening compound: 1-[4-(4-fluorophenyl)piperazin-1-yl]-2-[4-(1-methyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]ethan-1-one

F522-0331 Screening compound: 1-[4-(4-fluorophenyl)piperazin-1-yl]-2-[4-(1-methyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]ethan-1-one
F522-0331 Screening compound: 1-[4-(4-fluorophenyl)piperazin-1-yl]-2-[4-(1-methyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F522-0331
1-[4-(4-fluorophenyl)piperazin-1-yl]-2-[4-(1-methyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F522-0331

Molecular Formula

C21H26FN5O (C21 H26 FN5 O)

Compound Name

1-[4-(4-fluorophenyl)piperazin-1-yl]-2-[4-(1-methyl-1H-pyrazol-4-yl)-1,2,3,6-tetrahydropyridin-1-yl]ethan-1-one

IUPAC name

1-[4-(4-fluorophenyl)piperazin-1-yl]-2-[4-(1-methyl-1H-pyrazol-4-yl)-1236-tetrahydropyridin-1-yl]ethan-1-one

SMILES

Cn1ncc(C2=CCN(CC(N(CC3)CCN3c(cc3)ccc3F)=O)CC2)c1

InChI

InChI=1S/C21H26FN5O/c1-24-15-18(14-23-24)17-6-8-25(9-7-17)16-21(28)27-12-10-26(11-13-27)20-4-2-19(22)3-5-20/h2-6,14-15H,7-13,16H2,1H3

InChI Key

KXTAKVVKYYUPKC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27171978

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

383.47

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.770

Distribution Coefficient, logD

1.770

Water Solubility, LogSw

-2.08

Polar Surface Area

38.161

Acid Dissociation Constant (pKa)

24.66

Base Dissociation Constant (pKb)

3.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

F522-0331 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

DGK Inhibitors Library (10558 compounds)

Soluble Diversity Library (15920 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • Epigenetic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F522-0331 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F522-0331?
Check Price and Availability of F522-0331, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F522-0331 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F522-0331
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F522-0331
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F522-0331 available by request